Tattoos and Risk of Hematologic Cancer: A Population-Based Case-Control Study in Utah.

ABSTRACT:

Background

Approximately one-third of US adults have a tattoo, and the prevalence is increasing. Tattooing can result in long-term exposure to carcinogens and inflammatory and immune responses.

Methods

We examined tattooing and risk of hematologic cancers in a population-based case-control study with 820 cases diagnosed 2019-2021 and 8200 frequency-matched controls, ages 18-79 years. We calculated odds ratios (OR) and 95% confidence intervals (CI) using multivariable-adjusted logistic regression models.

Results

The prevalence of tattooing was 22% among Hodgkin lymphoma (HL) cases, 11% among non-Hodgkin lymphoma (NHL) cases, 16% among myeloid neoplasm cases, and 15% among controls. Though there were no clear patterns of associations between ever receiving a tattoo and

SUBMITTER: McCarty RD 

PROVIDER: S-EPMC11499570 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature